关于在上胃肠道内镜检查和随后的根除疗法期间测试Helicobacter pylori感染的专家的看法
Ilsoo Kim1, Sang Pyo Lee2, Jeong Wook Kim3
1Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
概括
韩国专家之间的Helicobacter pylori (H. pylori) 检测和治疗实践因相互矛盾的指导方针和退款标准而有所不同. 调整这些政策对于持续的患者护理和降低胃癌风险至关重要.
科学领域:
- 胃肠病学 胃肠病学
- 内部医学 内部医学
- 公共卫生政策 公共卫生政策
背景情况:
- 杆菌感染是胃癌和胃潰瘍的主要原因之一.
- 对H. pylori的根除疗法可以显著降低高风险人群的胃癌发病率.
- 韩国补偿标准和临床指南之间的差异对H. pylori管理构成挑战.
研究的目的:
- 调查有关在上部胃肠内镜检查期间H. pylori检测的专家看法和实践.
- 评估韩国胃肠病学家之间的H. pylori根除治疗决策.
- 在临床实践中确定影响H. pylori诊断和治疗策略的因素.
主要方法:
- 在2024年韩国球菌学院和上胃肠道研究夏季研讨会上,对51名专家进行了匿名的8个问题调查.
- 该调查探讨了各种临床指示和影响治疗决策的因素的H. pylori测试率.
- 数据分析的重点是根据患者的病情和退款资格来确定实践中的差异.
主要成果:
- 只有2%的专家对所有患者进行了H. pylori检测.
- 检测率各不相同:54%用于胃癌家族史,32%用于缩性胃炎,42%用于消化不良症状,62%用于缺铁性贫血.
- 82%的可接受选择性补偿的疑似H. pylori感染患者接受了测试;专家决定受到临床因素和经济负担的影响,而不仅仅是年龄.
结论:
- 对于H. pylori检测和根除治疗的专家实践是不一致的,受患者特定因素和经济考虑的影响.
- 临床指导方针和退款标准之间的不一致会造成混乱,并影响患者的护理.
- 建议包括将补偿政策与既定的临床指南协调一致,以确保标准化和适当的H. pylori管理.
相关概念视频
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
560
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
560
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
209
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
209
01:26Peptic Ulcer Disease IV: Management
150
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
150
01:23Gastritis III: Clinical Manifestations and Management
500
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
500
01:26Endoscopic Procedures V: ERCP
973
Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...
Patient...
973
01:29Endoscopic Procedures I: Esophagogastroduodenoscopy
359
An Esophagogastroduodenoscopy (EGD) is a diagnostic procedure in which an endoscopist uses a flexible, lighted endoscope to visualize the upper gastrointestinal (GI) tract. The procedure includes visualizing the oropharynx, esophagus, stomach, and the first part of the small intestine, the duodenum.
During an EGD, the endoscope can be used to:
During an EGD, the endoscope can be used to:
359